Assembling glyco-functionalized surfaces and membranes based on precision glycomacromolecules to study viral adhesion and inhibition

基于精密糖大分子组装糖功能化表面和膜来研究病毒粘附和抑制

基本信息

项目摘要

Recently, we have established the solid phase synthesis of monodisperse, sequence-defined glycopolymers or so-called precision glycomacromolecules. These precision glycomacromolecules are multivalent mimics of natural oligo- and polysaccharides exhibiting high avidity and selective binding to protein receptors. We were especially interested in gaining deeper insights into the structure-property correlation of such polymeric sugar mimetics. So far, commonly used polymeric scaffolds are not well defined with regard to multivalency and sugar presentations thus hampering direct correlations between ligand structures and binding partner. Through the stepwise assembly of our precision glycomacromolecules, we obtain perfect control over the chemical structure. By controlled variations of the different structural parameters and detailed analysis of the multivalent binding of the precision glycomacromolecules to sugar-recognizing protein receptors, we have learned about the different binding modes of glycomacromolecules and how to design efficient glycomacromolecule ligands e.g. for bacteria targeting. With this approach we are able to design suitable ligands from the ground up without tedious empirical optimization as is usually done. Here, we will apply our synthetic platform for a series of glycomacromolecules targeting different viruses. Together with the Peters lab, we will synthesize glycomacromolecules presenting different mono-, di- and trisaccharide fragments of histo-blood group antigen (HBGA) epitopes and will probe the multivalent binding site of murine noroviruses (Peters and Taube labs) and human noroviruses (Hansman lab). From the Blaum lab, we will obtain di- and tetrasaccharide fragments of heparan sulfate, which will be conjugated to the macromolecular scaffolds and evaluated for their binding to Merkel cell polyomavirus MCPyV (with the Blaum lab) and human papillomavirus 16 (HPV-16) (with the Schelhaas lab). For both viral targets, the synthesis of heteromultivalent glycomacromolecules will be addressed combining the sGAG fragments with sialic acid (Sia) (for MCPyV) or non-sulfated glycosaminoglycans (GAG) fragments (for HPV), respectively. It is an intrinsic advantage of the solid phase assembly to give access to heteromultivalent glycomacromolecules. Here the simultaneous presentation of the different glycans on one polymeric backbone will be used to probe the potential cooperative binding of the glycans for viral activation.
最近,我们已经建立了单分散,顺序定义的糖共聚物或所谓的精确糖大分子的固相合成。这些精密糖大分子是天然寡糖和多糖的多价模拟物,具有高亲和力和与蛋白质受体的选择性结合。我们特别感兴趣的是深入了解这种聚合糖模拟物的结构-性能相关性。到目前为止,常用的聚合物支架在多价性和糖的表现方面还没有很好的定义,从而阻碍了配体结构和结合伙伴之间的直接关联。通过我们的精密糖大分子的逐步组装,我们获得了对化学结构的完美控制。通过控制不同结构参数的变化,详细分析糖大分子与糖识别蛋白受体的多价结合,我们了解了糖大分子的不同结合模式,以及如何设计有效的糖大分子配体,如细菌靶向。通过这种方法,我们能够从头开始设计合适的配体,而无需像通常那样进行繁琐的经验优化。在这里,我们将应用我们的合成平台,针对不同的病毒进行一系列糖大分子的合成。我们将与Peters实验室合作,合成具有不同单糖、二糖和三糖的组织-血抗原(HBGA)表位的糖大分子,并探测鼠诺如病毒(Peters和Taube实验室)和人诺如病毒(Hansman实验室)的多价结合位点。从Blaum实验室,我们将获得硫酸肝素的二糖和四糖片段,它们将被偶联到大分子支架上,并评估它们与默克尔细胞多瘤病毒MCPyV (Blaum实验室)和人乳头瘤病毒16 (HPV-16) (Schelhaas实验室)的结合。对于这两种病毒靶点,将分别将sGAG片段与唾液酸(Sia)(用于MCPyV)或非硫酸糖胺聚糖(GAG)片段(用于HPV)结合来合成异多价糖大分子。固相组装的固有优点是可以获得异多价糖大分子。在这里,不同的聚糖同时呈现在一个聚合主链上,将被用来探测聚糖潜在的协同结合,以激活病毒。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professorin Dr. Laura Hartmann其他文献

Professorin Dr. Laura Hartmann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professorin Dr. Laura Hartmann', 18)}}的其他基金

Synthese monodisperser, multifunktionaler Neoglycopolymere und Neoglycopolymer-Hybride und ihre Anwendung in der Medizin
单分散、多功能新乙二醇聚合物和新乙二醇聚合物杂化物的合成及其在医学中的应用
  • 批准号:
    147522676
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Independent Junior Research Groups

相似国自然基金

Glyco-Let-7a 靶向 SIAE 抑制 NF-κB 信号修复 UC 肠粘膜屏障损伤的机制研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Spatial pathophysiological study on cardiorenal syndrome using novel tissue glyco-imaging technology
利用新型组织糖成像技术进行心肾综合征的空间病理生理学研究
  • 批准号:
    24K19073
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Next-generation cell therapy pioneered by glyco-editing
由糖编辑开创的下一代细胞疗法
  • 批准号:
    23K17372
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Pioneering a novel cancer targeting glyco-immunotherapy strategy
开创了一种新型癌症靶向糖免疫治疗策略
  • 批准号:
    2889867
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Analysis of immune responses induced by Glyco-Nanoadjuvants as vaccine platform
糖纳米佐剂作为疫苗平台诱导的免疫反应分析
  • 批准号:
    23K11853
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
REU Site: Glyco-Tree - Glycomaterial Training, Research and Education Experiences
REU 网站:Glyco-Tree - 糖材料培训、研究和教育经验
  • 批准号:
    2244483
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Synthesis of novel glyco-caged prodrugs to treat inflammatory bowel disease
合成新型糖笼前药治疗炎症性肠病
  • 批准号:
    574177-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Core B: Glyco-genomics and Bioinformatics
核心 B:糖基因组学和生物信息学
  • 批准号:
    10321578
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Targeting a bacterial glyco-Achilles heel to make new vaccines for Haemophilus influenzae and Neisseria gonorrhoeae.
针对细菌糖基阿基里斯之踵来制造流感嗜血杆菌和淋病奈瑟菌的新疫苗。
  • 批准号:
    nhmrc : 2001210
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Ideas Grants
Microenvironmental Regulation of Stem Cells via Forest and Marine Glyco-nanofibers
通过森林和海洋糖纳米纤维调节干细胞的微环境
  • 批准号:
    21K19150
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Systematic characterization of glyco-immune signaling networks with high-throughput functional genomics
利用高通量功能基因组学系统表征糖免疫信号网络
  • 批准号:
    456351
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了